rs4940876

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_133459.4(CCBE1):​c.401-29T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.992 in 1,598,734 control chromosomes in the GnomAD database, including 787,955 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.96 ( 70644 hom., cov: 34)
Exomes 𝑓: 1.0 ( 717311 hom. )

Consequence

CCBE1
NM_133459.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.566

Publications

8 publications found
Variant links:
Genes affected
CCBE1 (HGNC:29426): (collagen and calcium binding EGF domains 1) This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans. [provided by RefSeq, Mar 2010]
CCBE1 Gene-Disease associations (from GenCC):
  • Hennekam lymphangiectasia-lymphedema syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Hennekam syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 1 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 18-59466920-A-G is Benign according to our data. Variant chr18-59466920-A-G is described in ClinVar as Benign. ClinVar VariationId is 262353.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCBE1NM_133459.4 linkc.401-29T>C intron_variant Intron 4 of 10 ENST00000439986.9 NP_597716.1 Q6UXH8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCBE1ENST00000439986.9 linkc.401-29T>C intron_variant Intron 4 of 10 1 NM_133459.4 ENSP00000404464.2 Q6UXH8-1

Frequencies

GnomAD3 genomes
AF:
0.962
AC:
146348
AN:
152208
Hom.:
70593
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.868
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.985
Gnomad ASJ
AF:
0.992
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.984
Gnomad NFE
AF:
0.999
Gnomad OTH
AF:
0.967
GnomAD2 exomes
AF:
0.989
AC:
248218
AN:
250914
AF XY:
0.992
show subpopulations
Gnomad AFR exome
AF:
0.867
Gnomad AMR exome
AF:
0.991
Gnomad ASJ exome
AF:
0.992
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
0.999
Gnomad OTH exome
AF:
0.993
GnomAD4 exome
AF:
0.996
AC:
1440192
AN:
1446408
Hom.:
717311
Cov.:
25
AF XY:
0.996
AC XY:
717785
AN XY:
720536
show subpopulations
African (AFR)
AF:
0.871
AC:
28855
AN:
33136
American (AMR)
AF:
0.991
AC:
44203
AN:
44614
Ashkenazi Jewish (ASJ)
AF:
0.990
AC:
25676
AN:
25938
East Asian (EAS)
AF:
1.00
AC:
39456
AN:
39456
South Asian (SAS)
AF:
1.00
AC:
85874
AN:
85900
European-Finnish (FIN)
AF:
1.00
AC:
52752
AN:
52754
Middle Eastern (MID)
AF:
0.989
AC:
4996
AN:
5052
European-Non Finnish (NFE)
AF:
0.999
AC:
1099271
AN:
1099892
Other (OTH)
AF:
0.991
AC:
59109
AN:
59666
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
270
540
810
1080
1350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21390
42780
64170
85560
106950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.961
AC:
146459
AN:
152326
Hom.:
70644
Cov.:
34
AF XY:
0.963
AC XY:
71718
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.868
AC:
36072
AN:
41544
American (AMR)
AF:
0.985
AC:
15087
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.992
AC:
3445
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5188
AN:
5188
South Asian (SAS)
AF:
0.999
AC:
4827
AN:
4832
European-Finnish (FIN)
AF:
1.00
AC:
10620
AN:
10620
Middle Eastern (MID)
AF:
0.983
AC:
289
AN:
294
European-Non Finnish (NFE)
AF:
0.999
AC:
67978
AN:
68044
Other (OTH)
AF:
0.967
AC:
2041
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
277
554
830
1107
1384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.968
Hom.:
15436
Bravo
AF:
0.956
Asia WGS
AF:
0.992
AC:
3449
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 100% of patients studied by a panel of primary immunodeficiencies. Number of patients: 95. Only high quality variants are reported. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hennekam lymphangiectasia-lymphedema syndrome 1 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
3.6
DANN
Benign
0.75
PhyloP100
-0.57
BranchPoint Hunter
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4940876; hg19: chr18-57134152; API